Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;36(3):179-86.
doi: 10.1007/s10875-016-0245-x. Epub 2016 Feb 27.

Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency

Affiliations

Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency

Johanna Schepp et al. J Clin Immunol. 2016 Apr.

Abstract

Purpose: Determining the monogenic cause of antibody deficiency and immune dysregulation in a non-consanguineous family with healthy parents, two affected children, and one unaffected child.

Methods: Whole Exome Sequencing (WES) was performed in the index family. WES results were confirmed by Sanger Sequencing. Dried plasma spots of the male patient and his mother were analyzed for ADA2 enzymatic activity.

Results: Following data analysis of WES, we found a compound heterozygous mutation in CECR1 (encoding adenosine deaminase 2, ADA2) that segregated in the two affected children. Enzyme activity measurement confirmed a severely diminished ADA2 activity in our patient. The 32 year old index patient was suffering from recurrent respiratory infections and was previously diagnosed with common variable immunodeficiency (CVID), showing no signs of vasculitis. His sister had a systemic lupus erythematosus (SLE)-like phenotype and died at age 17.

Conclusions: Deficiency of ADA2 (DADA2) has been reported to cause vasculopathy and early-onset stroke. Our case suggests that it should also be considered when evaluating patients with antibody deficiencies and immune dysregulation syndromes.

Keywords: Deficiency of ADA2; antibody deficiency; common variable immunodeficiency; primary immunodeficiency; recurrent infections; systemic lupus erythematosus.

PubMed Disclaimer

References

    1. Arthritis Rheum. 1997 Sep;40(9):1725 - PubMed
    1. Neurology. 2015 May 19;84(20):2092-3 - PubMed
    1. Nat Methods. 2012 Mar 04;9(4):357-9 - PubMed
    1. Clin Immunol. 1999 Dec;93(3):190-7 - PubMed
    1. Genome Res. 2010 Sep;20(9):1297-303 - PubMed

Publication types

MeSH terms